Schrodinger, Inc. (SDGR): Gross Profit
$142.61M
Year ended 2025-12-31
$147.31M
Trailing 12 months to 2026-06-30
+12.2%
3-year compound annual growth
+17.6%
5-year compound annual growth
| Period ended | Gross Profit | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $142.61M | +8.0% | 2026-02-25, From 2025-01-01 |
| 2024-12-31 | $132.08M | -6.1% | 2026-02-25, From 2024-01-01 |
| 2023-12-31 | $140.69M | +39.3% | 2026-02-25, From 2023-01-01 |
| 2022-12-31 | $101.02M | +54.0% | 2025-02-26, From 2022-01-01 |
| 2021-12-31 | $65.62M | +3.4% | 2024-02-28, From 2021-01-01 |
| 2020-12-31 | $63.47M | +29.3% | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | $49.09M | n/a | 2022-02-24, From 2019-01-01 |
Gross Profit at similar companies
| Company | Year ended | Gross Profit | Change YoY |
|---|---|---|---|
| Schrodinger, Inc. (SDGR) | 2025-12-31 | $142.61M | +8.0% |
| Vireo Growth Inc. (VREOF) | 2025-12-31 | $127.10M | +150.3% |
| Harrow, Inc. (HROW) | 2025-12-31 | $204.37M | +35.9% |
| Akebia Therapeutics, Inc. (AKBA) | 2025-12-31 | $196.73M | +102.8% |
| Puma Biotechnology, Inc. (PBYI) | 2025-12-31 | $170.21M | +2.5% |
| Evolus, Inc. (EOLS) | 2025-12-31 | $197.11M | +8.1% |
| Amarin Corp PLC (AMRN) | 2025-12-31 | $120.87M | +48.5% |
| CorMedix Inc. (CRMD) | 2025-12-31 | $275.75M | +584.5% |
| Rhythm Pharmaceuticals, Inc. (RYTM) | 2025-12-31 | $170.26M | +45.8% |
Compare SDGR, VREOF, HROW, AKBA side by side · Screen every company in Pharmaceutical Preparations ↗